LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2021 Results - Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (LGND) Q1 2021 Earnings Conference Call May 03, 2021, 2:30 PM ET Company Participants John Higgins - Chief Executive Officer Matthew Korenberg - Executive Vice President, Finance and Chief Financial Officer Matthew Foehr - President and Chief Operating Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright Lawrence Solow - CJS Securities Balaji Prasad - Barclays Matt Hewitt - Craig-Hallum Capital Scott Henry - ROTH Capital Dana Flanders - Guggenheim Presentation Operator Good afternoon and thank you for standing by. Welcome to the Ligand Pharmaceuticals Quarter One Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Simon [indiscernible]. Sir, the floor is yours. Unidentified Company Representative Thanks Rachel. Welcome to Ligand's first quarter of 2021 financial results
For further details see:
Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q1 2021 Results - Earnings Call Transcript